From professional translators, enterprises, web pages and freely available translation repositories.
acide 2-amino-5-phosphonovalérique
2 amino 5 phosphonovalerate
Last Update: 2014-12-09
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
ap5 (acide 2-amino-5-phosphonovalérique)
2 amino 5 phosphonovalerate
Last Update: 2014-12-09
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
les antagonistes des récepteurs compétitifs de n-méthyl-d-aspartate (nmda) [acide (3-(±)2-carboxypipérazine-4-yl)-propyl-1-phosphonique (cpp), acide dl-2-amino-7-phosphosphonoheptanoïque (aph), acide dl-2-amino-5-phosphonovalérique (apv), acide d-α-aminodipique (aaa), et acide dl-α,ε-diaminopimélique (dap)] et l'antagoniste non compétitif de nmda (+)-5-méthyl-10,11-dihydro-5h-dibenzo[a,d]cycloheptène-5,10-imine maléate (mk-801) ont provoqué des augmentations fonctions de la dose de la période de latence entre le déclenchement des crises.
both competitive n-methyl-d-aspartate (nmda) receptor antagonists [(3-(±)2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (cpp), dl-2-amino-7-phosphosphonoheptanoic acid (aph), dl-2-amino-5-phosphonovaleric acid (apv), d-α-aminoadipic acid (aaa), and dl-α,ε-diaminopimelic acid (dap)] and the noncompetitive nmda antagonist (+)-5-methyl-10,11-dihydro-5h-dibenzo [a,d] cyclohepten-5,10-imine maleate (mk-801) produced dose-dependent increases in latency to the onset of seizures.
Last Update: 2015-05-14
Usage Frequency: 1
Quality:
